Home

Welcome

We are a leader in therapeutic innovation, pharmaceutical education, and clinical pharmacy. Driven by scientific curiosity and an entrepreneurial spirit, our vibrant community of faculty, staff, scholars, and learners are united behind our mission to expand knowledge and improve the health of people everywhere. 

Learn more about our school

In NIH research funding

No. 1

First-gen students

37%

California’s trailblazing spirit is embodied in our students who are the first in their families to earn a college degree.

Education

Our academic programming across PharmD, Master’s, PhD, and postdoctoral education prepares you to become innovative leaders in pharmacy, precision medicine, and science. Join our school’s community of critical thinkers and help shape health care.

PharmD Degree Program

The UCSF doctor of pharmacy (PharmD) degree curriculum is a science-based, integrated, experiential course of study that prepares ambitious minds for diverse and dynamic careers in pharmacy and beyond.

Read more about the program

MS in AICD3

Our Master of Science in Artificial Intelligence and Computational Drug Discovery and Development program trains students to apply computer science, data science, statistical analysis, machine learning, and other data-driven methods to redefine the discovery and development of new drugs and therapies. This program is offered with the Graduate Division.

Read about MS in AICD3

PhD Degree Programs

We administer five PhD degree programs, all of which promote an interdisciplinary approach to science and education. The programs are delivered by faculty members in the School of Pharmacy and the School of Medicine. All are offered by the Graduate Division.

Read about our PhD offerings

Postdoctoral Programs

Our postdoctoral programs are pharmacy residencies, fellowships, and postdoctoral research. We also offer career-development courses in medical product development, pharmacokinetics, and tobacco cessation.

Read about our postdoctoral programs

Departments

Our school is comprised of three departments and the Quantitative Biosciences Institute that work together to advance health.

  • Bioengineering and Therapeutic Sciences

    Exploring the complex processes of biology and applying what we learn to the development and rational use of therapeutics to improve health.

  • Clinical Pharmacy

    Advancing the safe and effective use of therapeutics to improve health.

  • Pharmaceutical Chemistry

    Exploring fundamental biological mechanisms and molecules of therapeutic relevance for better health, empowered by novel technologies at the interface of chemistry, physics, and computational sciences.

  • Quantitative Biosciences Institute (QBI)

    Fostering collaborations across the biomedical and the physical sciences while seeking quantitative methods to address pressing problems in biology and biomedicine.

News

  • Parella with Executive Vice Dean Sharon Youmans, PharmD ’85, MPH

    Suzan Revah

    Trusting the Process: Steven Parella Finds His Path in Pharmacy

    Steven Parella, PharmD ’19, is a clinical pain pharmacist with Kaiser Permanente in Roseville, CA. He manages the Opioid Safety Tapering Program, conducting telephone consultations with patients taking high-dose opioids and gradually tapering their medications while introducing non-opioid treatments for additional pain relief. He also provides coverage for a hospice clinic one day a week. 

  • Liang Zhao in lab

    Suzan Revah

    Testing AI’s Promise for Life Sciences

    Working in close collaboration with OpenAI colleagues, Liang Zhao, PhD, MAS, MBA, and his team at the UCSF School of Pharmacy are developing a benchmark to evaluate how well AI tools can perform scientific tasks. Included among the tools is GPT-Rosalind, a domain-specific large language model designed for life sciences such as genomics and drug discovery. 

  • headshots of Bill DeGrado, James Fraser and Tanja Kortemme

    Katherine Tam

    Researchers Leverage AI to Design New Generation of Enzymes

    A team of UCSF School of Pharmacy researchers led by professor James Fraser has been selected for a new U.S. Department of Energy initiative aimed at harnessing artificial intelligence to accelerate scientific discovery.